Child and Parental Characteristics of Medication Use for Attention-Deficit/Hyperactivity Disorder

Beate Oerbeck1, Kari Furu2, Pal Zeiner1

  • 1Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Insights

Medication use for attention-deficit/hyperactivity disorder (ADHD) in children is primarily linked to child characteristics, not parental factors. This large study found that disruptive symptoms at age 3 predicted medication use for ADHD.

Area of Science:

  • Pediatric Psychiatry
  • Neurodevelopmental Disorders
  • Pharmacological Treatments

Background:

  • Attention-deficit/hyperactivity disorder (ADHD) is a common neurodevelopmental disorder affecting children.
  • Understanding factors associated with ADHD medication use is crucial for effective treatment strategies.
  • Previous research has explored both child and parental characteristics influencing treatment decisions.

Purpose of the Study:

  • To investigate child and parental characteristics associated with medication use in children diagnosed with ADHD.
  • To compare characteristics between medicated and unmedicated children with ADHD within a large prospective cohort.

Main Methods:

  • Utilized data from the Norwegian Mother, Father and Child Cohort Study (MoBa) linked to prescription and patient registries.
  • Analyzed data from 1,764 children with ADHD (ICD-10: F90, F98.8) between 2008-2013.
  • Compared child characteristics (including early disruptive and ADHD symptoms) and parental factors between medicated and unmedicated groups.

Main Results:

  • 77% of children with ADHD used medication, with no gender difference in medication use or age at first prescription.
  • Medicated children showed significantly more hyperkinetic conduct disorders and lower global functioning.
  • Higher disruptive symptoms at age 3 were significantly associated with medication use; ADHD symptoms at age 3 were close to significant.

Conclusions:

  • Child characteristics, particularly early disruptive symptoms, are significantly associated with ADHD medication use.
  • Parental factors like education and psychopathology did not significantly predict medication use in this cohort.
  • Established clinical practices likely influence medication prescription, especially for hyperkinetic conduct disorder in a high-income setting.

Related Concept Videos

Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
612
Conduct Disorder01:28

Conduct Disorder

Conduct disorder is a complex mental health diagnosis characterized by a repetitive and persistent pattern of behavior that violates societal norms, the rights of others, or age-appropriate rules. The diagnostic criteria for conduct disorder require the presence of at least three problematic behaviors within the past 12 months, with at least one occurring in the past six months. These behaviors are grouped into four categories: aggression toward people and animals; destruction of property;...
356
Oppositional Defiant Disorder01:30

Oppositional Defiant Disorder

A persistent pattern of angry or irritable mood, defiant behavior, or vindictiveness characterizes Oppositional Defiant Disorder (ODD). Symptoms must occur over at least six months, involve interactions with individuals beyond siblings, and meet specific diagnostic criteria to be clinically significant. The disorder affects emotional regulation, social interactions, and behavior, often manifesting early in life and influencing long-term development and functioning.
Diagnostic Criteria and...
429
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
148